journal article·2026-01

The application of 3D cell culture for melanoma in vitro models

Kailei Xu, Jing Wu, Zehuan Li, Wenjie Chen, Peng Wei, Miaoben Wu

Acta Biomaterialia· Volume 209
Publisher page

Abstract

Melanoma remains a formidable clinical challenge due to its high metastatic potential and resistance to conventional therapies, in part reflecting the failure of two-dimensional (2D) culture systems to recapitulate the complex tumor microenvironment (TME). Three-dimensional (3D) cell culture models have emerged as superior platforms over traditional 2D systems for recapitulating the complex TME of melanoma, including native extracellular matrix (ECM) architecture, cell-cell interactions, and biochemical gradients essential for accurate drug screening and mechanistic studies. In this review, we conducted a comprehensive literature survey to classify and critically evaluate melanoma 3D culture platforms into five categories, including melanoma spheroids, biomaterial-encapsulation cultures, melanoma skin equivalents, melanoma-on-chip, and bio-printed melanoma model, focusing on biomaterial composition, architectural fidelity, mechanical properties, and cellular integration, and systematically comparing their advantages and disadvantages. These models have advanced our understanding of melanoma progression, drug resistance mechanisms, cellular behavior, and they offer more reliable platforms for drug screening and development of personalized therapies. Although numerous challenges still need to be tackled, like the current biomaterials seldom replicate the distinct ECM of different skin layers and often neglect the incorporation of immune cells and adipocytes, emerging technologies hold promises for overcoming these challenges by enabling precise fabrication of tissue complexity, incorporation of vasculature, and integration of immune components. These innovations are poised to enhance the physiological relevance of melanoma models, ultimately facilitating the development of more effective treatments and improving patient outcomes. STATEMENT OF SIGNIFICANCE: Melanoma remains a formidable clinical challenge due to its high metastatic potential and resistance to conventional therapies. 3D cell culture models have emerged as superior platforms over traditional 2D systems for recapitulating the complex TME of melanoma. In this review, we classified melanoma 3D cell culture models into five categories, including melanoma spheroids, biomaterial-encapsulation cultures, melanoma skin equivalents, melanoma-on-chip, and bio-printed melanoma model, focusing on biomaterial composition, architectural fidelity, mechanical properties, and cellular integration, and systematically comparing their benefits and costs. In addition, we also highlighted the challenges of the development on melanoma 3D culture platforms for drug screening and mechanistic studies and discussed the future perspective on the development on melanoma 3D culture platforms.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cancer Cells and Metastasis · Melanoma and MAPK Pathways

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Effects of biomechanical forces on the biological behavior of cancer stem cells10.7150/jca.60893 ↗
2. Global burden of cutaneous melanoma in 2020 and projections to 204010.1001/jamadermatol.2022.0160 ↗
3. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma10.1016/S0046-8177(84)80310-X ↗
4. The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas10.1001/archderm.144.4.476 ↗
5. Treatment of metastatic melanoma: an overview
7. Targeted agents and immunotherapies: optimizing outcomes in melanoma10.1038/nrclinonc.2017.43 ↗
8. Tumor microenvironment: implications in melanoma resistance to targeted therapy and immunotherapy10.3390/cancers12102870 ↗
9. Therapeutic targeting of the tumor microenvironment10.1158/2159-8290.CD-20-1808 ↗
10. Impact of the physical microenvironment on tumor progression and metastasis10.1016/j.copbio.2016.02.007 ↗
11. The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture10.1038/s41467-020-16583-0 ↗
12. The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression10.1172/JCI143763 ↗
13. The extracellular matrix: tools and insights for the "omics" era10.1016/j.matbio.2015.06.003 ↗
14. The extracellular matrix as a key regulator of intracellular signalling networks10.1111/bph.14195 ↗
15. Age-related evolutions of the dermis: clinical signs, fibroblast and extracellular matrix dynamics10.1016/j.mad.2018.03.006 ↗
16. Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility10.1158/2159-8290.CD-18-0193 ↗
17. Ultraviolet light-induced collagen degradation inhibits melanoma invasion10.1038/s41467-021-22953-z ↗
18. Fibronectin in cell adhesion and migration via N-glycosylation10.18632/oncotarget.19969 ↗
19. Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT10.2147/OTT.S195703 ↗
20. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression10.1016/j.semcancer.2008.03.007 ↗
21. Hyaluronic acid-based wound dressings: a review10.1016/j.carbpol.2020.116364 ↗
22. Hyaluronic acid-CD44 interactions promote BMP4/7-dependent Id1/3 expression in melanoma cells
23. Melanoma cells produce multiple laminin isoforms and strongly migrate on α5 laminin(s) via several integrin receptors10.1016/j.yexcr.2010.12.019 ↗
24. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion10.1002/path.2045 ↗
25. Stromal cells in the tumor microenvironment: accomplices of tumor progression?10.1038/s41419-023-06110-6 ↗
26. Focal adhesion kinase promotes the aggressive melanoma phenotype10.1158/0008-5472.CAN-05-2172 ↗
27. Profiling cancer-associated fibroblasts in melanoma10.3390/ijms22147255 ↗
28. The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma10.1016/j.bbcan.2020.188456 ↗
29. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β10.1097/CMR.0000000000000325 ↗
30. Retinoic acid inhibits tumor-associated mesenchymal stromal cell transformation in melanoma10.3389/fcell.2021.658757 ↗
31. Obesity and melanoma: could fat be fueling malignancy?10.1111/pcmr.12584 ↗
32. Promotion of melanoma growth by the metabolic hormone leptin10.3892/or_00000713 ↗
33. Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer10.1158/0008-5472.CAN-16-0651 ↗
34. Glucose metabolism of TAMs in tumor chemoresistance and metastasis10.1016/j.tcb.2023.03.008 ↗
35. Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies10.1080/2162402X.2022.2127284 ↗
36. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L110.1186/s13073-020-00780-z ↗
37. Diverse matrix metalloproteinase functions regulate cancer amoeboid migration10.1038/ncomms5255 ↗
38. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis10.1038/cr.2015.17 ↗
39. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer10.1158/1078-0432.CCR-11-0699 ↗
40. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis10.1016/j.canlet.2015.01.012 ↗
41. Microenvironmental regulation of tumour angiogenesis10.1038/nrc.2017.51 ↗
42. VEGF/VEGFR axis and its signaling in melanoma: current knowledge toward therapeutic targeting agents and future perspectives10.1016/j.lfs.2024.122563 ↗
43. Extracellular matrix in development: insights from mechanisms conserved between invertebrates and vertebrates10.1101/cshperspect.a005082 ↗
44. Pellet culture model for human primary osteoblasts10.22203/eCM.v020a13 ↗
45. A simple hanging drop cell culture protocol for generation of 3D spheroids10.3791/2720 ↗
46. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation10.1186/1741-7007-10-29 ↗
47. Advances in the formation, use and understanding of multi-cellular spheroids10.1517/14712598.2012.707181 ↗
48. Hanging drop cultures of human testis and testis cancer samples: a model used to investigate activin treatment effects in a preserved niche10.1038/bjc.2014.160 ↗
49. Spheroid culture differentially affects cancer cell sensitivity to drugs in melanoma and RCC models10.3390/ijms23031166 ↗
50. Breast cancer MCF-7 cell spheroid culture for drug discovery and development10.4236/jct.2022.133009 ↗
51. A novel spheroid-based co-culture model mimics loss of keratinocyte differentiation, melanoma cell invasion, and drug-induced selection of ABCB5-expressing cells10.1186/s12885-019-5606-4 ↗
52. A multidisciplinary study using in vivo tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cells10.3109/1547691X.2014.891677 ↗
53. Tumour associated vasculature-on-a-chip for the evaluation of microbubble-mediated delivery of targeted liposomes10.1039/D2LC00963C ↗
54. New strategy for promoting vascularization in tumor spheroids in a microfluidic assay10.1002/adhm.202201784 ↗
55. In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed10.1007/s10456-022-09842-9 ↗
56. A linkable, polycarbonate gut microbiome-distal tumor chip platform for interrogating cancer promoting mechanisms
57. A preclinical model of cutaneous melanoma based on reconstructed human epidermis10.1038/s41598-022-19307-0 ↗
58. La Carrubba, V. PLLA scaffolds with controlled architecture as potential microenvironment for in vitro tumor model10.1016/j.tice.2019.04.004 ↗
59. Breast cancer cell cultures on electrospun poly(ε-Caprolactone) as a potential tool for preclinical studies on anticancer treatments10.3390/bioengineering8010001 ↗
60. Stiff matrix induces exosome secretion to promote tumour growth10.1038/s41556-023-01092-1 ↗
61. Studying cancer stem cell dynamics on PDMS surfaces for microfluidics device design10.1038/srep02332 ↗
62. Circulating tumor cell phenotype detection and epithelial-mesenchymal transition tracking based on dual biomarker Co-recognition in an integrated PDMS chip
63. Electrospun Polylactic acid (PLLA) microtube array membrane (MTAM)-an advanced substrate for anticancer drug screening10.3390/ma12040569 ↗
64. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases10.1158/1535-7163.MCT-06-0084 ↗
65. In vitro ovarian cancer model based on three-dimensional agarose hydrogel10.1177/2041731413520438 ↗
66. Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies10.1039/D2LC00244B ↗
67. Patient-derived melanoma organoid models facilitate the assessment of immunotherapies10.1016/j.ebiom.2023.104614 ↗
68. Influence of Matrigel on single- and multiple-spheroid cultures in breast cancer research10.1177/2472555219834698 ↗
69. Dynamic cell culture modulates colon cancer cell migration in a novel 3D cell culture system10.1038/s41598-024-69261-2 ↗
70. A novel three-dimensional model to quantify metastatic melanoma invasion10.1158/1535-7163.MCT-06-0593 ↗
71. Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models10.1016/j.actbio.2016.12.037 ↗
72. A 3D collagen-based bioprinted model to study osteosarcoma invasiveness and drug response10.3390/polym14194070 ↗
73. A vascularized in vivo melanoma model suitable for metastasis research of different tumor stages using fundamentally different bioinks
74. Construction of a lung cancer 3D culture model based on alginate/gelatin micro-beads for drug evaluation10.21037/tlcr-24-490 ↗
75. Gelatin-based 3D biomimetic scaffolds platform potentiates culture of cancer stem cells in esophageal squamous cell carcinoma10.1016/j.biomaterials.2023.122323 ↗
76. Evaluation of the effect of fibroblasts on melanoma metastasis using a biomimetic Co-culture model10.1021/acsbiomaterials.2c01186 ↗
77. Structure establishment of three-dimensional (3D) cell culture printing model for bladder cancer10.1371/journal.pone.0223689 ↗
78. 3D printed porous microgel for lung cancer cells culture in vitro10.1016/j.matdes.2021.110079 ↗
79. Three-dimensional decellularized tumor extracellular matrices with different stiffness as bioengineered tumor scaffolds
80. Engineered liver-derived decellularized extracellular matrix-based three-dimensional tumor constructs for enhanced drug screening efficiency10.1093/rb/rbae113 ↗
81. Micropatterns of Matrigel for three-dimensional epithelial cultures10.1016/j.biomaterials.2007.05.021 ↗
82. UC-MSCs promote frozen-thawed ovaries angiogenesis via activation of the wnt/β-catenin pathway in vitro ovarian culture system10.1186/s13287-022-02989-8 ↗
83. Collagen formation, function and role in kidney disease10.1038/s41581-024-00902-5 ↗
84. Characterization of high affinity binding motifs for the Discoidin domain receptor DDR2 in Collagen*♦10.1074/jbc.M709290200 ↗
85. Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet glycoprotein VI contains two glycine-proline-hydroxyproline triplets*10.1074/jbc.M606479200 ↗
86. Recombinant collagen and gelatin for drug delivery10.1016/j.addr.2003.08.008 ↗
87. The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability10.1016/j.biomaterials.2013.09.078 ↗
88. A 3D culture system for evaluating the combined effects of cisplatin and anti-fibrotic drugs on the growth and invasion of lung cancer cells co-cultured with fibroblasts10.1063/5.0115464 ↗
89. Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment10.1016/j.biomaterials.2022.121527 ↗
90. A 3D bioprinted tumor model fabricated with gelatin/sodium alginate/decellularized extracellular matrix bioink10.18063/ijb.v9i1.630 ↗
91. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines10.1097/CMR.0b013e32836314e3 ↗
92. Multicellular tumor spheroids as a model for assessing delivery of oligonucleotides in three dimensions10.1038/mtna.2014.5 ↗
93. TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness10.1186/s13046-018-0982-1 ↗
94. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway10.1016/j.amjsurg.2014.09.014 ↗
95. Tumor cells and their crosstalk with endothelial cells in 3D spheroids10.1038/s41598-017-10699-y ↗
96. Protocol to generate scaffold-free, multicomponent 3D melanoma spheroid models for preclinical drug testing10.1016/j.xpro.2024.103058 ↗
97. Assembloid models of cell-cell interaction to study tissue and disease biology10.1016/j.stem.2024.09.017 ↗
98. Generation of 3D melanoma models using an assembloid-based approach10.1016/j.actbio.2024.02.023 ↗
99. Shan, H.; Chen, M.; Zhao, S.; Wei, X.; Zheng, M.; Li, Y.; Lin, Q.; Jiang, Z.; Chen, Z.; Fei, C.; et al. Acoustic virtual 3D scaffold for direct-interacting tumor organoid–immune cell coculture systems. Sci. Adv. 10 (47), eadr4831. DOI: 10.1126/sciadv.adr4831 (acccessed 2025/06/17).10.1126/sciadv.adr4831 ↗
100. A tumorigenic subpopulation with stem cell properties in melanomas10.1158/0008-5472.CAN-05-1343 ↗